Literature DB >> 8666327

Behavior of various cholesterol crystals in bile from patients with gallstones.

P Portincasa1, K J van Erpecum, A Jansen, W Renooij, M Gadellaa, G P vanBerge-Henegouwen.   

Abstract

Besides classical plate-like cholesterol monohydrate crystals, a variety of crystal shapes have recently been described in model biles but their relevance for human gallstone formation is unknown. We therefore studied crystallization behavior in gallbladder bile from cholesterol stone patients (54 untreated, 13 ursodeoxycholate-treated) and 6 pigment stone patients. Bile preparation by ultrafiltration or ultracentrifugation left biliary lipid composition unchanged but plates and their aggregates, and arcs and needles crystallized more extensively while spirals and tubules crystallized less extensively in ultra-centrifuged bile than in ultrafiltered bile. Plates, aggregates, and arcs/needles were seen in 90 percent, 36 percent, and 18 percent of the cases respectively of fresh unfiltered biles of untreated cholesterol stone patients, while spirals and tubules were always absent. In ultrafiltered biles arcs/needles, plates and aggregates progressively developed as persistent forms. Spirals and tubules occurred transiently and were associated with increased deoxycholic acid (+41 percent, P = .039) and with more extensive cholesterol crystallization. Rate/extent of crystallization of all crystal forms was higher (P < .0001) for multiple than solitary cholesterol stone patients. Ursodeoxycholate-treated patients had atypical platelike cholesterol crystals in fresh unfiltered biles that decreased in size at prolonged observation and in 2 cases even dissolved after 15 and 20 days. No crystals ever developed in ultra-filtered bile of ursodeoxycholic acid (UDCA)-treated patients during 21 days. Pigment stone patients seldom developed crystals. Thus, plates, aggregates and arcs/needles are persistent forms with high crystallization rate in multiple cholesterol stone patients. Tubules and spirals are transient forms that are associated with more extensive crystallization. Patients treated with ursodeoxycholate often have atypical crystals in their fresh bile.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666327     DOI: 10.1002/hep.510230414

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

1.  Engineered three-dimensional liver mimics recapitulate critical rat-specific bile acid pathways.

Authors:  Christopher J Detzel; Yeonhee Kim; Padmavathy Rajagopalan
Journal:  Tissue Eng Part A       Date:  2010-12-19       Impact factor: 3.845

Review 2.  Primary sclerosing cholangitis: updates in diagnosis and therapy.

Authors:  Piero Portincasa; Michele Vacca; Antonio Moschetta; Michele Petruzzelli; Giuseppe Palasciano; Karel J van Erpecum; Gerard P van Berge-Henegouwen
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

Review 3.  Targets for current pharmacologic therapy in cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q H Wang; Helen H Wang; Leonilde Bonfrate; Piero Portincasa
Journal:  Gastroenterol Clin North Am       Date:  2010-06       Impact factor: 3.806

Review 4.  Cholesterol crystallisation in bile.

Authors:  P Portincasa; K J van Erpecum; G P Vanberge-Henegouwen
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

Review 5.  Management of patients with a short bowel.

Authors:  J M Nightingale
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

6.  Gastrointestinal defects in gallstone and cholecystectomized patients.

Authors:  Agostino Di Ciaula; Emilio Molina-Molina; Leonilde Bonfrate; David Q-H Wang; Dan L Dumitrascu; Piero Portincasa
Journal:  Eur J Clin Invest       Date:  2019-01-29       Impact factor: 4.686

7.  Therapy of gallstone disease: What it was, what it is, what it will be.

Authors:  Piero Portincasa; Agostino Di Ciaula; Leonilde Bonfrate; David Qh Wang
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-04-06

8.  Circulating Fatty Objects and Their Preferential Presence in Pancreatic Cancer Patient Blood Samples.

Authors:  Ruoxiang Wang; Nicholas N Nissen; Yi Zhang; Chen Shao; Chia-Yi Chu; Carissa Huynh; Edwin M Posadas; James S Tomlinson; Michael S Lewis; Stephen J Pandol
Journal:  Front Physiol       Date:  2022-02-14       Impact factor: 4.566

9.  The physical presence of gallstone modulates ex vivo cholesterol crystallization pathways of human bile.

Authors:  Piero Portincasa; Karel J van Erpecum; Agostino Di Ciaula; David Q-H Wang
Journal:  Gastroenterol Rep (Oxf)       Date:  2018-12-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.